We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+5.56%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$3.93B
AUM Growth
+$360M
Cap. Flow
+$411M
Cap. Flow %
10.43%
Top 10 Hldgs %
59.89%
Holding
121
New
32
Increased
23
Reduced
19
Closed
35

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$311M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$256M
3
LNG icon
Cheniere Energy
LNG
+$228M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$223M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$132M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$327M
2
PXD
Pioneer Natural Resource Co.
PXD
+$73.9M
3
LYB icon
LyondellBasell Industries
LYB
+$69.9M
4
MCD icon
McDonald's
MCD
+$68.8M
5
TCO
Taubman Centers Inc.
TCO
+$63.4M

Sector Composition

Rank Sector Weight
1 Healthcare 33.72%
2 Communication Services 14.55%
3 Energy 13.79%
4 Industrials 10.45%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBIX icon
26
Neurocrine Biosciences
NBIX
$18.2B
$29.7M 0.75%
525,000
-62,662
-11% -$3.18M
ARIA
27
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$26.6M 0.68%
4,250,000
+750,000
+21% +$4.92M
ZLTQ
28
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$26.1M 0.66%
915,100
+70,400
+8% +$2.22M
SRPT icon
29
Sarepta Therapeutics
SRPT
$1.6B
$26M 0.66%
675,000
+275,000
+69% +$8.92M
CHTR icon
30
Charter Communications
CHTR
$16.9B
$23.8M 0.61%
130,189
-157,836
-55% -$29.2M
YPF icon
31
YPF
YPF
$19.9B
$22.4M 0.57%
1,423,263
+631,100
+80% +$11.5M
JD icon
32
JD.com
JD
$43.1B
$22M 0.56%
+681,000
New +$20.1M
PCRX icon
33
Pacira BioSciences
PCRX
$1.04B
$21.1M 0.54%
275,000
-75,000
-21% -$4.25M
ILMN icon
34
Illumina
ILMN
$29.1B
$20.8M 0.53%
111,330
-158,004
-59% -$25.5M
DD icon
35
DuPont de Nemours
DD
$18.5B
$20.5M 0.52%
+156,965
New +$20.1M
NFLX icon
36
Netflix
NFLX
$300B
$20.3M 0.52%
+1,774,000
New +$20.3M
LTRPA
37
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$20.1M 0.51%
660,925
-54,075
-8% -$1.59M
BYD icon
38
Boyd Gaming
BYD
$6.71B
$18.5M 0.47%
928,875
+103,875
+13% +$2M
SBAC icon
39
SBA Communications
SBAC
$19B
$16.8M 0.43%
159,900
-321,300
-67% -$34.8M
ACAD icon
40
Acadia Pharmaceuticals
ACAD
$4.43B
$16M 0.41%
+450,000
New +$15.9M
ABBV icon
41
AbbVie
ABBV
$471B
$14.8M 0.38%
250,000
– –
BXLT
42
DELISTED
BAXALTA INC COM STK (DE)
BXLT
$13.7M 0.35%
350,000
-1,150,000
-77% -$40.1M
PENN icon
43
PENN Entertainment
PENN
$2.83B
$13.1M 0.33%
817,112
+217,112
+36% +$3.65M
IPXL
44
DELISTED
Impax Laboratories, Inc.
IPXL
$12.8M 0.33%
+300,000
New +$12M
RLYP
45
DELISTED
RELYPSA INC COM
RLYP
$12.8M 0.32%
+450,000
New +$9.69M
WMT icon
46
Walmart Inc
WMT
$905B
$12.3M 0.31%
601,800
-1,099,800
-65% -$22.1M
AMAG
47
DELISTED
AMAG Pharmaceuticals
AMAG
$12.1M 0.31%
+400,000
New +$12.9M
STZ icon
48
Constellation Brands
STZ
$22.7B
$11.7M 0.3%
+82,000
New +$11.3M
BWLD
49
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$11.6M 0.29%
+72,400
New +$12.1M
CHK
50
PUT
DELISTED
Chesapeake Energy Corporation
CHK
$11.3M 0.29%
12,500
– –
1
2
3 4 5

Similar funds

CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
IMRF
Illinois Municipal Retirement Fund Oak Brook, Illinois $7.86B AUM 24.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
CMTU
Capital Markets Trading (UK) London, United Kingdom $7.95B AUM 85.98% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

PointState Capital's Q4 2015 Portfolio in Review

As of Q4 2015, PointState Capital held 121 positions worth $3.93B, up 10% from $3.57B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

PointState Capital deployed $411M of net new capital in Q4 2015, opening 32 new positions and adding to 23 existing holdings. Its largest new stake was Allergan plc: 1,043,500 shares worth $326M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 17% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was Pioneer Natural Resource Co., an estimated $73.9M trimmed.

  • PointState Capital's largest Q4 2015 buy was Allergan plc: 1,043,500 shares worth $326M.
  • PointState Capital added most to Teva Pharmaceuticals in Q4 2015, an estimated $256M increase.
  • PointState Capital's biggest Q4 2015 reduction was Pioneer Natural Resource Co., cutting an estimated $73.9M.
  • PointState Capital fully exited Alphabet (Google) Class C in Q4 2015, selling an estimated $327M.
  • PointState Capital's ten largest holdings make up 60% of its $3.93B portfolio in Q4 2015.
  • PointState Capital opened 32 new positions and closed 35 in Q4 2015.
  • PointState Capital's portfolio value rose 10% quarter-over-quarter to $3.93B.

Based on PointState Capital's 13F filing for Q4 2015, filed 16 Feb 2016.